Saying Sorry May Not Be Good Enough For Novartis

Novartis has issued a formal apology over misconduct relating to valsartan (Diovan) research in Japan, but that apology does not appear likely to satisfy the Japanese Health, Labor and Welfare Ministry, which plans to fully investigate the company’s role in the scandal. If necessary, ministry officials are prepared to raid the company’s offices in Japan. A Novartis official apologized to the Japanese public for the apparent manipulation of data. David Epstein, the head of the pharmaceutical division at Novartis, met with the Japanese health minister. ”We express our deep regret for the concern that the issue has brought More…
Source: CardioBrief - Category: Cardiology Authors: Tags: Uncategorized blood pressure Japan Novartis scientific misconduct valsartan Source Type: blogs